The short answer: unit price is the wrong metric
If you're buying medical supplies or equipment for a clinic, hospital, or lab, the lowest quoted unit price is almost never the lowest total cost. Across about $180,000 in cumulative medical procurement spending—maybe $175,000, I'd have to check our system—I found that roughly 34% of budget overruns came from hidden costs: setup fees, service contracts, training, consumables, and reorders caused by misaligned specs. That's not a vendor problem. It's a TCO problem.
So when someone asks me about molnlycke, or molnlycke mepiform with safetac technology, or even unrelated categories like a dental unit, a holter monitor, or what is gel electrophoresis, I give them the same framework: match clinical need, validate evidence, calculate total cost, and verify the supplier. Everything else is noise.
Why you should trust this (or at least check my math)
I'm a procurement manager at a 120-person multi-specialty clinic. I've managed our medical supply and equipment budget—about $220,000 annually—for 6 years. I've negotiated with 40+ vendors, and I document every order in our cost tracking system. When I audited our 2023 spending, I found three categories where we were paying a premium for the wrong reasons: wound care dressings, diagnostic devices, and lab reagents.
Per FTC advertising guidelines (ftc.gov), medical claims must be truthful, not misleading, and substantiated with evidence. That applies to vendors and to us. If a supplier says a dressing reduces pain or a device improves outcomes, they need clinical data. If they can't show it, I don't budget for it.
Mölnlycke and the Mepiform question
Mölnlycke is a global medical device company best known for wound care, surgical gloves, surgical drapes and gowns, and infection prevention products. You'll see the molnlycke health care logo on products like Mepilex, Mepiform, Melgisorb, Biogel, and Barrier. In procurement, that logo matters for one reason: verification. Counterfeit or diverted products exist, and checking the logo, lot number, and authorized distributor is a basic step I now require after a 2022 incident where a 'discount' supplier shipped expired dressings.
Mepiform with Safetac technology is a silicone gel dressing often used for scar management. Safetac is Mölnlycke's silicone adhesive technology designed to be gentle on skin during dressing changes. The clinical pitch is less pain and less trauma to the wound bed and surrounding skin. In my experience, that can translate to fewer dressing changes and less nursing time—which is a real cost. But it's not a magic bullet. I've seen clinicians use it for hypertrophic scars and keloids; I've also seen it be the wrong choice for infected or heavily exuding wounds. The product's cost only makes sense when the clinical need matches the indication.
Here's the counterintuitive part: the 'expensive' Mepiform option sometimes beats the budget gauze-based approach on total cost. Not because gauze is bad—it's not—but because frequent, painful dressing changes add up. Nurse time, patient discomfort, and wasted supplies can cost more than the premium dressing. That said, I'm not sure why some vendors quote wildly different prices for the same Mepiform box. My best guess is bundled service contracts, regional distributor margins, and volume tiers. If someone has better insight, I'd love to hear it.
For surgical products, the same logic applies. Mölnlycke's Biogel gloves and Barrier drapes compete on fit, allergy profile, and fluid resistance. A cheaper glove that tears or causes dermatitis can cost more in wasted time and staff discomfort. But you still need to check sizing, sterilization, and supply reliability. The logo alone doesn't guarantee the right fit.
Dental unit, Holter monitor, and gel electrophoresis: same TCO logic, different specs
A dental unit is the chairside equipment that powers a dental clinic's chair—handpieces, suction, water, air, and lighting. When buying a dental unit, the unit price is only the starting point. Installation, plumbing, compressor capacity, maintenance contracts, and handpiece repairs can add 20-40% over 5 years. The maintenance contract alone can run $1,200-$2,500 annually. I learned this in 2020 when we compared three dental units for a satellite clinic. One quoted $12,000 less than the others. Then we read the fine print: the warranty excluded handpiece wear, and the suction required a separate $3,000 upgrade. That 'cheap' option was actually $1,800 more expensive over 3 years.
A holter monitor is a portable ECG device used to record heart rhythm over 24-48 hours or longer. If you're buying Holter monitors for a cardiology clinic, the device cost is maybe 40% of the total. Software licensing, electrodes, patient belts, scanning/analysis fees, and data storage are recurring costs. Cloud subscriptions can run $30-$80 per patient study. I saved $80 by skipping expedited shipping on a Holter monitor order once. Ended up spending $400 on a rush reorder when the standard delivery missed our clinic's deadline. That's a classic penny-wise, pound-foolish mistake.
What is gel electrophoresis? It's a lab technique that separates DNA, RNA, or proteins by size and charge using an electric field in a gel matrix. Clinical and research labs use it for diagnostics, genetics, and quality control. If you're sourcing gel electrophoresis equipment or reagents, the TCO includes the power supply, gel trays, stains, running buffers, and waste disposal. A basic setup might cost $2,000-$5,000, but reagents and stains can add $1,000-$3,000 annually. A cheaper power supply might lack programmable voltage or safety features, which can ruin a $500 gel and waste hours of tech time.
Where this framework breaks down
This approach was accurate as of January 2025. Medical device pricing, distributor policies, and product indications change fast, so verify current rates, FDA clearances, and clinical guidelines before you budget. Also, TCO isn't everything. If a clinic lacks the staff to maintain a high-end dental unit, or a lab can't validate a gel electrophoresis protocol, the cheapest long-term option may still be the wrong one.
And honestly, I still get surprised by procurement. The surprise wasn't the price difference. It was how much hidden value came with the premium option for certain patients—fewer dressing changes, less nursing time, better scar outcomes. But for other patients, the same product was way more expensive with no clinical benefit. So treat TCO as a decision tool, not a religion. Check the evidence, run the numbers, and talk to the clinicians who use the product every day.
